Guiding rare immune cells may help HIV vaccines trigger broadly neutralizing antibodies

Researchers have developed a strategy that steers rare immune cells toward producing broadly neutralizing antibodies against HIV. The approach, described in Nature, represents a key step in vaccine design. If successful in humans, it could enable a vaccine that protects against diverse HIV strains.

Sources (1)